Abstract

Human erythrocytes parasitized with the malarial protozoan Plasmodium falciparum showed rates of L-lactate, D-lactate, and pyruvate uptake many fold greater than control cells. Thus it was necessary to work at 0 degrees C to resolve true initial rates of transport. Studies on the dependence of the rate of transport on substrate concentration implied the presence in parasitized cells of both a saturable mechanism blocked by alpha-cyano-4-hydroxycinnamate (CHC) and a nonsaturable mechanism insensitive to CHC. The former was dominant at physiological substrate concentrations with Km values for pyruvate and D-lactate of 2.3 and 5.2 mM, respectively, with no stereoselectivity for L- over D-lactate. CHC was significantly less effective as an inhibitor of lactate transport in parasitized erythrocytes than in uninfected cells, whereas p-chloromercuribenzenesulfonate, a potent inhibitor in control cells, gave little or no inhibition of lactate transport into parasitized erythrocytes. Inhibition of transport into infected cells was also observed with phloretin, furosemide, niflumic acid, stilbenedisulfonate derivatives, and 5-nitro-2-(3-phenylpropylamino)benzoic acid at concentrations similar to those that inhibit the lactate carrier of control erythrocytes. These compounds were more effective inhibitors of the rapid transport of chloride into infected cells than of lactate transport, whereas CHC was more effective against lactate transport. This implies that different pathways are involved in the parasite-induced transport pathways for lactate and chloride. The transport of L-lactate into infected erythrocytes was also inhibited by D-lactate, pyruvate, 2-oxobutyrate, and 2-hydroxybutyrate. The intracellular accumulation of L-lactate at equilibrium was dependent on the transmembrane pH gradient, suggesting a protogenic transport mechanism. Our data are consistent with lactate and pyruvate having direct access to the malarial parasite, perhaps via the proposed parasitophorous duct or some close contact between the host cell and parasite plasma membranes, with transport across the latter by both a proton-linked carrier (CHC-sensitive, saturable, and the major route) and free diffusion of the undissociated acid (CHC-insensitive, unsaturable, and a minor route).

Highlights

  • Human erythrocytes parasitized with the malarial protozoan Plasmodium falciparum showed rates of Llactate, n-laetate, and pyruvate uptake many fold greater than control cells

  • Ifthe parasitophorous duct does not exist, a new pathway for lactic acid transport out of the host cell would need to be induced in the host cell membrane since the activity of the endogenous transporter is insufficient to account for the increased fluxes of lactic acid observed in infected cells [4, 7]

  • In the present paper we provide a detailed account of the characteristics of lactate and other monocarboxylates transported into human red cells infected with P. falciparum

Read more

Summary

11 To whomcorrespondence should be addressed

Dept. ofBiochemistry, School of Medical Sciences, University of Bristol, Bristol Walk, Bristol BS8 lTD, U. It is probable that the enhanced permeability is caused by the export of parasite-derived proteins to the host plasma membrane, but parasite-induced changes in the properties of host cell plasma membrane proteins such as Band 3 cannot be ruled out [19,20,21,22,23,24] It is unclear whether there are a variety of new transport pathways induced in the infected cell or whether a nonspecific channel is opened which allows entry of any small molecule, but with a preference for anions [18]. Our data are most interpreted if lactate and pyruvate have direct access to the malarial parasite, perhaps via the proposed parasitophorous duct or some close contact between the host cell and parasite plasma membranes, with transport across the latter occurring by both a proton-linked carrier (CHC1-sensitive, saturable, and the major route) and free diffusion of the undissociated acid (CHC-insensitive, unsaturable and a minor route)

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.